HighMark Wealth Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

HighMark Wealth Management’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-550	Closed	-$549	–	610
2023 Q3	$549	Hold	550	–	–	﹤0.01%	529
2023 Q2	$270	Hold	550	–	–	﹤0.01%	536
2023 Q1	$638	Hold	550	–	–	﹤0.01%	559
2022 Q4	$1.47K	Hold	550	–	–	﹤0.01%	453
2022 Q3	$2K	Hold	550	–	–	﹤0.01%	452
2022 Q2	$3K	Hold	550	–	–	﹤0.01%	418
2022 Q1	$4K	Buy	+550	New	+$4.55K	﹤0.01%	402

HighMark Wealth Management's CELL Position: Q4 2023 in Review

HighMark Wealth Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 550 shares — an estimated $549 sold.

HighMark Wealth Management first reported a position in CELL in Q1 2022 and held it in 7 quarters. The position peaked at $4K in Q1 2022. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

HighMark Wealth Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
HighMark Wealth Management sold 550 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $549.
HighMark Wealth Management first reported a position in PhenomeX Inc. Common Stock in Q1 2022 and held it in 7 quarters.
HighMark Wealth Management's PhenomeX Inc. Common Stock position peaked at $4K in Q1 2022.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on HighMark Wealth Management's 13F filing for Q4 2023, filed 23 Jan 2024.